). In addition, we found evidence for a basolateral P2X receptor. Here, we investigate the effect of basolateral ATP on NaCl absorption in isolated, perfused mouse mTALs using the electrical measurement of equivalent short-circuit current (I= sc). Nonstimulated mTALs transported at a rate of 1,197 Ϯ 104 A/cm 2 (n ϭ 10), which was completely blockable with luminal furosemide (100 M). Basolateral ATP (100 M) acutely (1 min) and reversibly reduced the absorptive I= sc. After 2 min, the reduction amounted to 24.4 Ϯ 4.0% (n ϭ 10). The nonselective P2 receptor antagonist suramin blocked the effect. P2Y receptors were found not to be involved in this effect. The P2X receptor agonist 2-methylthio ATP mimicked the ATP effect, and the P2X receptor antagonist periodate-oxidized ATP blocked it. In P2X 7 Ϫ/Ϫ mice, the ATP effect remained unaltered. In contrast, in P2X 4 Ϫ/Ϫ mice the ATP-induced inhibition of transport was reduced. A comprehensive molecular search identified P2X 4, P2X5, and P2X1 receptor subunit mRNA in isolated mouse mTALs. These data define that basolateral ATP exerts a significant inhibition of Na ϩ absorption in mouse mTAL. Pharmacological, molecular, and knockout mouse data identify a role for the P2X 4 receptor. We suggest that other P2X subunits like P2X5 are part of the P2X receptor complex. These data provide the novel perspective that an ionotropic receptor and thus a nonselective cation channel causes transport inhibition in an intact renal epithelium. purinergic; renal transport; loop of Henle; P2 receptors; P2X 4 RENAL TUBULAR TRANSPORT IS highly regulated by systemic hormones such as parathyroid hormone, vasopressin, and aldosterone. In addition, numerous local auto-and paracrine factors have pronounced modulating effects on renal epithelial ion transport. These local factors include ANG II (13), endothelin (9), prostaglandins (2), nitric oxide (16), and extracellular nucleotides (20). Extracellular nucleotides have widespread effects on the entire renal tubular transport system and elicit their effects via luminal and basolateral purinergic P2 receptors (11, 20) . Most commonly, P2 receptor stimulation leads to the inhibition of ion and water transport (8, 20, 21, 27 ). Nucleotide-mediated transport inhibition has been shown, e.g., in the proximal tubule for HCO 3 Ϫ absorption or in the distal tubule for aquaporin-2 (AQP2)-or epithelial Na ϩ channel (ENaC)-meditated water or Na ϩ transport (1, 7, 10, 18) . In the loop of Henle, a recent study measured O 2 consumption in a bulk cellular preparation of enzymatically isolated rat medullary thick ascending limbs (mTAL) (22). It could be shown, that extracellular ATP caused a ϳ30% inhibition of O 2 consumption. The data are compatible with extracellular ATP causing the inhibition of transcellular NaCl absorption. In one of our previous studies, we investigated the functional expression of luminal and basolateral P2 receptor-mediated increases in intracellular Ca 2ϩ in isolated, perfused mouse mTAL (5). These studies were conducted in P2Y 2 receptor wild-type (P2Y 2 ϩ/ϩ ) and P2Y 2 receptor knockout (P2Y 2 Ϫ/Ϫ ) mice. In the apical membrane, we identified the P2Y 2 receptor with no evidence for other P2 receptors. In the basolateral membrane, the P2Y 2 receptor was also present. In addition, we found that in both P2Y 2 ϩ/ϩ and P2Y 2 Ϫ/Ϫ tissue basolateral ATP stimulated a sustained elevation of intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), which was dependent on the presence of basolateral extracellular Ca 2ϩ . These results therefore suggested that mouse mTALs also expresses a basolateral P2X receptor.
RENAL TUBULAR TRANSPORT IS highly regulated by systemic hormones such as parathyroid hormone, vasopressin, and aldosterone. In addition, numerous local auto-and paracrine factors have pronounced modulating effects on renal epithelial ion transport. These local factors include ANG II (13) , endothelin (9) , prostaglandins (2), nitric oxide (16) , and extracellular nucleotides (20) . Extracellular nucleotides have widespread effects on the entire renal tubular transport system and elicit their effects via luminal and basolateral purinergic P2 receptors (11, 20) . Most commonly, P2 receptor stimulation leads to the inhibition of ion and water transport (8, 20, 21, 27) . Nucleotide-mediated transport inhibition has been shown, e.g., in the proximal tubule for HCO 3 Ϫ absorption or in the distal tubule for aquaporin-2 (AQP2)-or epithelial Na ϩ channel (ENaC)-meditated water or Na ϩ transport (1, 7, 10, 18) . In the loop of Henle, a recent study measured O 2 consumption in a bulk cellular preparation of enzymatically isolated rat medullary thick ascending limbs (mTAL) (22) . It could be shown, that extracellular ATP caused a ϳ30% inhibition of O 2 consumption. The data are compatible with extracellular ATP causing the inhibition of transcellular NaCl absorption. In one of our previous studies, we investigated the functional expression of luminal and basolateral P2 receptor-mediated increases in intracellular Ca 2ϩ in isolated, perfused mouse mTAL (5) . These studies were conducted in P2Y 2 receptor wild-type (P2Y 2 ϩ/ϩ ) and P2Y 2 receptor knockout (P2Y 2 Ϫ/Ϫ ) mice. In the apical membrane, we identified the P2Y 2 receptor with no evidence for other P2 receptors. In the basolateral membrane, the P2Y 2 receptor was also present. In addition, we found that in both P2Y 2 ϩ/ϩ and P2Y 2 Ϫ/Ϫ tissue basolateral ATP stimulated a sustained elevation of intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), which was dependent on the presence of basolateral extracellular Ca 2ϩ . These results therefore suggested that mouse mTALs also expresses a basolateral P2X receptor.
The aim of this project was to investigate the effect of extracellular ATP on NaCl absorption in mouse mTAL. For this purpose, we used the isolated, perfused tubule technique and the recording of the transepithelial electrical parameters to quantify the equivalent short-circuit current (I= sc ) and thus NaCl absorption. We focused on the effect of basolateral nucleotides on active transport in this tubule segment. We identify an acute, substantial, and reversible inhibition of the electrogenic NaCl absorption by basolateral ATP. Pharmacological data show that this effect is mediated via P2X receptors. Molecular data underscore this finding and functionally identify the P2X 4 receptor as part of a likely heteromeric P2X receptor complex.
MATERIALS AND METHODS
Animals. Experiments were performed using 4-to 7-wk-old mice of either sex. Animals had free access to a standard rodent diet and tap water. Mouse handling and breeding were approved by Danish animal welfare regulations (Dyreforssøgstilsynet, approval number 2005/ 562-31). In this study, the mice were of a mixed genetic background (B6D2/SV129). The P2X 7 receptor knockout mice originated from the GlaxoSmithKline (GSK) clone and were bred in the BALB/c genetic background. The P2X 4 receptor knockout mouse was similarly a gift from GSK and maintained in C57BL/6 background. All mice were bred in house.
Tubule perfusion and measurement of ion transport in mTAL. Mice were euthanized by cervical dislocation. Both kidneys were removed and placed in ice-cold control solution (see below) before being sliced as described (28) . The slices were transferred to a dissection chamber cooled to 4°C. mTALs were isolated in control solution (see below) from the inner stripe of the outer medulla (ISOM) using fine forceps. Kidney tubules were transferred to a perfusion chamber on an inverted microscope. Isolated tubules were perfused by a system of concentric glass pipettes (4). The tubule was placed directly on the glass bottom of the experimental chamber and perfused from one side leaving the other end open. An additional holding pipette was often used to stabilize the preparation. The measurement of ion transport in isolated, perfused tubules was done as described before using a doublebarreled perfusion pipette (10) . Shortly thereafter, the transepithelial voltage difference (V te) was measured via one barrel between the lumen and a reference electrode placed in the bath. Via a silver wire placed into the other barrel, a small current pulse of 38.7 nA was injected in the tubular lumen and measured as a voltage deflection (⌬V 0). The length and diameter of the tubules were documented with transmission video imaging to quantify the tubule's cable properties. The cable equation was then used to determine the resistance of the tissue (R te in ⍀·cm 2 ). Applying Ohm's law, equivalent I=sc (in A/ cm 2 ) was then calculated as a measure of ion transport in the mTAL. Molecular identification of P2Y and P2X receptor mRNA from isolated mTALs. The isolation of total RNA from control tissues (CNS, lung, liver, colon, and kidney) and ISOM was performed with an RNeasy Mini Kit in the QIAcube (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The isolation of total RNA from microdissected, isolated mTALs was performed with an RNeasy Micro Kit (Qiagen) according to the manufacturer's instructions. For each RNA isolation, we used ϳ5.5 mm of isolated mTAL tubules. cDNA was synthesized from 1 g total RNA in a 20-l reaction volume using 0.5 l (10 U) SuperScriptIII reverse transcriptase (Invitrogen, Carlsbad, CA) along with 0.25 l (50 U) Superase·In (Ambion, Austin, TX) and 1 M of random decamers (Eurofins MWG Operon, Ebersberg, Germany). RT reactions were carried out according to the manufacturer's instructions.
PCRs were performed on a Flexcycler (Analytik Jena, Jena, Germany) with AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster City, CA) in Buffer II (Applied Biosystems) supplemented with 2.5 mM MgCl 2. PCR cycles consisted of an initial step of 94°C for 5 min with 37 subsequent cycles of 94°C for 30 s, 55-64°C for 45s and 72°C for 1 min, and a final extension of 72°C for 10 min. mTAL PCRs were performed in a double reaction: first a PCR was carried out with 20 reaction cycles from which 1 l was used in a 37-cycle reaction. Annealing temperatures were 58°C for P2X 2 and P2X6, 60°C for P2X7, 62°C for P2X3, P2X5, P2Y2, P2Y4, P2Y6, P2Y12, P2Y13 and P2Y14, and 64°C for P2X1, P2X4, and P2Y1. Table 1 shows the primer pairs used for all P2 receptors studied. Primers were designed to span at least one intron. As a negative control, minus RT experiments were performed simultaneously. PCR products were analyzed on agarose gels via ethidium bromide staining. Sequencing of the PCR products confirmed the specificity of the PCR amplifications (Eurofins MWG Operon).
Solutions and chemicals. Experiments were performed at 37°C with the following control solution (in mM): 145 NaCl, 1 MgCl 2, 1.3 Ca-gluconate, 5 D-glucose, 0.4 KH2PO4, 1.6 K2HPO4, and 5 HEPES. Solutions were titrated with NaOH to pH 7.4 (37°C).
All chemicals were obtained from Sigma-Aldrich Denmark (Vallensbaek, Denmark), Tocris Bioscience (Bristol, UK), and Merck (Darmstadt, Germany). Agonist solutions were prepared directly before the experiment.
Statistics. Data are shown as means Ϯ SE. For experimental series, n reflects the number of tubules used. On average, two tubules were used from each mouse. Normal distribution was confirmed by the Kolmogorov-Smirnov test. For non-normal-distributed series, the Mann-Whitney test was used to compare mean values. Paired t-tests were used to compare mean values within one experimental series. A P value of Ͻ0.05 was accepted to indicate statistical significance. Figure 1A shows an original recording of V te in a perfused mouse mTAL. This tubule had a lumen-positive V te of 9.4 mV. In this series, the basal and stable transepithelial electrical parameters 10 -15 min after the start of the perfusion were V te 7.23 Ϯ 0.47 mV, R te 6.3 Ϯ 0.47 ⍀·cm 2 , and I= sc 1,197 Ϯ 104 A/cm 2 (n ϭ 10) (Fig. 1B) . In a separate series of experiments, luminal furosemide (100 M) reduced V te from 6.23 Ϯ 0.49 to 1.05 Ϯ 0.30 mV (n ϭ 4), reporting a nearly complete inhibition of transport. Figure 1A also shows the effect of basolateral ATP (100 M) applied for 2 min. Immediately after the addition of ATP, V te dropped to 7.5 mV, stayed reduced within the 2 min, and returned to control values after 3-4 min. R te stayed unaltered during the application of basolateral ATP. In Fig. 1B , a summary of this series is shown. The analysis of I= sc revealed the effect on transport: while ATP is present there is a marked reduction of I= sc to 956 Ϯ 109 A/cm 2 , reflecting a ϳ24% transport inhibition. The effect of ATP on I= sc was reversible. Interestingly, after 7 min of washout, the measured I= sc reached higher values compared with the prestimulatory value (Fig. 1B) . Figure 1B displays the individual V te results of all 10 experiments. The concentrationresponse curve of ATP ranging from 100 nM to 500 M is shown in Fig. 2 . The IC 50 value was calculated to be close to 10 M. These data define that basolateral ATP triggers a pronounced inhibition of ion transport in mouse mTAL. P2 receptor-mediated transport inhibition. ATP is an unstable molecule, easily broken down in the extracellular environment by ectonucleotidases, eventually leading to the formation of adenosine (29) . The renal epithelium expresses both P2 and adenosine receptors well established to modulate transport (20, 25) . We therefore tested the effect of the nonspecific P2 receptor blocker suramin on the ATP-induced effect. Figure 3 shows that basolateral suramin (100 M) completely and reversibly inhibited the ATP-triggered (10 M) effect on transport. In addition, we demonstrate that adenosine (100 M) was unable to mimic the effect of ATP (Fig. 4) . These results strongly indicate that the ATP-induced inhibition of NaCl absorption occurs via P2 receptors and not via adenosine receptors.
RESULTS

Basolateral ATP-induced ion transport inhibition in mouse mTAL.
No effect of basolateral P2Y receptor agonists on ion transport in mouse mTAL. We previously described that the P2Y 2 receptor is functionally expressed in the apical and basolateral membrane of mouse mTAL (5) . UTP is a specific agonist for the P2Y 2 and P2Y 4 receptor. In this study, we find that basolateral UTP (100 M) did not mimic the ATP effect (Figs. 4 and 5A, n ϭ 7) . In addition, we studied the effect of basolateral ATP in mTAL from P2Y 2 Ϫ/Ϫ mice. An original trace in Fig. 5B shows that ATP was able to trigger full transport inhibition in the absence of this receptor. No difference was observed in the ATP effect in the P2Y 2 ϩ/ϩ and P2Y 2 Ϫ/Ϫ mouse tissue (n ϭ 7-10, P ϭ 0.57). These data clearly indicate that the P2Y 2 receptor is not mediating the effect of basolateral ATP. Furthermore, other P2Y receptor agonists like UDP and ADP had no effect (Fig. 4) . These data strongly suggest that basolateral P2Y receptors are not responsible for the ATP-dependent inhibition of transport in mouse mTAL.
P2X receptors mediate transport inhibition in mouse mTAL. A preceding paper identified that basolateral ATP in both P2Y 2 Ϫ/Ϫ and P2Y 2 ϩ/ϩ mice triggered a sustained influx of Ca 2ϩ , compatible with the presence of basolateral P2X receptors (5). The involvement of an ionotropic ATP receptor was further investigated by a stable ATP-like compound, 2-methylthio ATP (2MeSATP), which is known to activate several P2X receptors. 2MeSATP (100 M) induced transport inhibition comparable to ATP (Fig. 4) . Periodate-oxidized ATP (oATP) is an antagonist of P2X receptors and has been shown not to have any effects on the P2Y receptors (12) . In Fig. 6 , we show the effect of this compound. In paired experiments we found that oATP (50 M, preincubation of 3-5 min) abolished the action of ATP (100 M). In time control experiments, ATP always was able to trigger a second or third response of similar magnitude (data not shown). Taken together, these data indicate the presence of a basolateral P2X receptor, which mediates an ATP-induced decrease in ion transport in mouse mTAL.
Identification of the P2X receptor mediating transport inhibition in mouse mTAL. To identify the P2X receptor subtype, we used ␣,␤-methylene ATP (␣,␤-meATP) and ␤,␥-methylene ATP (␤,␥-meATP) as relatively specific P2X 1 and P2X 3 receptor agonists (3). As seen in Fig. 4 , both agonists had no effect. Other pharmacological tools to distinguish between P2X receptors are often unspecific and thus preclude a definitive interpretation of the results. We therefore chose to use P2X receptor knockout mice for further exploration of the candidate P2X receptors. First, we used the P2X 7 Ϫ/Ϫ mouse. A summary of the functional measurements in P2X 7 ϩ/ϩ and P2X 7 Ϫ/Ϫ mouse mTAL is shown in Fig. 7 . No apparent differences were observed. Thus we conclude that the P2X 7 receptor appears not to be essential to mediate the ATP effect.
Next, we studied the P2X 4 Ϫ/Ϫ mouse. In P2X 4 Ϫ/Ϫ and P2X 4 ϩ/ϩ mTALs, ATP elicited its well-defined effect. However, it became apparent that the ATP-induced drop in V te was significantly smaller in P2X 4 Ϫ/Ϫ tissue (Fig. 8A) . In P2X 4 ϩ/ϩ tissue, basolateral ATP inhibited 29.6 Ϯ 0.25% of transport compared with a significantly reduced inhibition to 22.9 Ϯ 0.9% in P2X 4 Ϫ/Ϫ mTAL. These results indicate that the P2X 4 receptor at least in part mediates the ATP-induced inhibition of transport in mouse mTAL.
P2 receptor mRNA expression in isolated mouse mTAL. We next performed a comprehensive investigation of P2 receptor mRNA expression in isolated mouse mTAL. For all P2 receptors, positive controls were established from reference mouse tissues (see Fig. 9 and Table 2 ). The mTAL is localized in the ISOM and comprises ϳ90% of tissue mass in this part of the kidney. We therefore studied to find which of the P2 receptors are expressed in the ISOM. As can be seen in Fig. 9 , we found positive results for the following P2X subunits: P2X 1 , P2X 2 , P2X 3 , P2X 4 , P2X 5 , and P2X 7 . Five single ISOM RNA isolations were valued sufficient to confirm this expression pattern (Table 2) . Thus these six P2X subunits could be expressed in the isolated mTAL. Subsequently, we found positive results for the P2X 1 , P2X 4 , and the P2X 5 subunit in isolated mTAL tubules. Three isolations were viewed as sufficient to confirm this pattern. These data are in agreement with the functional data in the P2X 4 Ϫ/Ϫ mouse and indicate its involvement in the basolateral ATP effect. These results also suggest that P2X 5 possibly participates in the observed ATP action. To provide a comprehensive overview of all P2 receptors, we also studied the expression of the P2Y receptors. The same strategy as above was used, and we found positive results for the P2Y 2 and P2Y 6 receptor in isolated mTAL ( Fig. 10 and Table 2 ).
DISCUSSION
Renal tubular transport is modulated by local purinergic signals. Along the entire renal tubule, apical and basolateral P2 receptors have been identified. In several tubular segments, P2 receptor stimulation triggers a marked inhibition of tubular absorption. Thus auto-and paracrine ATP appears to act as an endogenous local diuretic molecule. ATP can be released from the renal epithelium either constitutively (15, 26) , after primary cilium bending (19) , or when classic hormones such as AVP stimulate the tubule (15) . Most transport studies investigating purinergic effects on renal epithelia have focused on the collecting duct (8, 23, 24, 27 ). In the thick ascending limb, the effect of extracellular ATP on ion transport has been unclear. Recently, in isolated rat mTAL tubule suspensions extracellular ATP was found to reduce O 2 consumption (22) . This was associated with tubular transport, since the pharmacological inhibition of type 3 Na ϩ -H ϩ cotransporter and Na ϩ -K ϩ -2Cl Ϫ cotransporter reduced O 2 use and under these conditions ATP could not trigger a further decrease in O 2 expenditure. These results support a role for extracellular ATP in mTAL transport function. In the current project, we directly investigated the effect of ATP on tubular transport in isolated, perfused mouse mTAL. We found that basolateral ATP triggered a marked and reversible reduction of the lumen-positive V te in a concentration-dependent manner. R te remained unaltered by basolateral ATP. Thus basolateral ATP promptly and reversibly inhibited some 24% of equivalent I= sc , reflecting a marked inhibition of active NaCl transport. The ATP effect in mouse mTAL is mediated via a P2 receptor, as shown by the unspecific purinergic receptor antagonist suramin. We then set out to indentify the involved P2 receptors that trigger the inhibitory response. This involved pharmacological, molecular, and knockout mouse experiments. First, we studied the G protein-coupled P2Y receptors. Preceding functional and molecular evidence indicated the expression of basolateral and apical P2Y 2 receptors in mouse mTAL (5, 17) . In the current study, we found that the P2Y 2 receptor agonist UTP added to the basolateral side did not trigger transport inhibition. Furthermore, in P2Y 2 Ϫ/Ϫ mice basolateral ATP triggered a pronounced inhibition of transport. These experiments exclude the involvement of the P2Y 2 receptor. Other typical P2Y receptor agonists like ADP and UDP were tested and did not have an effect on the transepithelial electrical parameters. Thus the P2Y 6 , receptor although expressed in isolated mouse mTAL (Fig. 10) , also does not mediate an inhibition of transport. In summary, these experiments exclude that the observed ATP effect is mediated via basolateral P2Y receptors. These results strongly point to a basolateral P2X receptor in mouse mTAL that mediates the ATP effect. Indeed, we suggested the functional expression of a basolateral P2X receptor in a preceding study (5) . In P2Y 2 Ϫ/Ϫ mTALs, we found that basolateral ATP triggered a marked and sustained Ca 2ϩ influx (5) . In this study, the involvement of a basolateral P2X receptor was further supported by pharmacological data. The nonselective P2X receptor agonist 2MeSATP similarly caused transport inhibition. In addition, the irreversible P2X receptor blocker oATP completely abolished the effect. These results provide strong evidence that a basolateral P2X receptor is involved. The pharmacological tools used on rat mTAL tubule suspensions similarly suggested a P2X receptor-mediated reduction of O 2 consumption (22) . However, the pharmacological profile did not permit the identification of the P2X receptor subtype. Altogether, seven P2X receptor subtypes are found in the mouse genome. P2X receptors are composed of three subunits, which together create a central ion-conductive pore (6, 14) . Either homo-or heteromeric P2X receptors can assemble to a functional channel. Typically, homomeric P2X 1 and P2X 3 receptors show very transient (within a few seconds) inward currents (14) . We found that P2X 1 and P2X 3 receptor agonists (e.g., ␣,␤meATP) did not trigger transport inhibition. Therefore, homomeric P2X 1 and P2X 3 receptors appear not to be involved. On the contrary, homomeric P2X 2 , P2X 4 , P2X 5 , and P2X 7 receptors elicit sustained receptor activation seen as sustained influx of cations (14) . In our experiments, we stimulated mTALs for 2 min with ATP and observed a sustained inhibition of transport. This observation suggests that one of the latter P2X receptors mediates this effect. Given the absence of subtype-specific P2X receptor antagonists, we then studied mTALs from P2X 7 Ϫ/Ϫ and P2X 4 Ϫ/Ϫ mice. Clearly, no difference was observed between P2X 7 ϩ/ϩ and P2X 7 Ϫ/Ϫ mice. This is congruent with the absence of P2X 7 receptor mRNA in isolated mTALs. On the contrary, we found a significant reduction of the ATP effects in mice deplete of the P2X 4 receptor. A comprehensive search for P2X receptor mRNA expression revealed that freshly dissected mTALs express the P2X 1 , P2X 4 , and P2X 5 receptors. Thus our data strongly suggest that the P2X 4 receptor is involved in the basolateral ATP-induced inhibition of NaCl absorption. In this context, it is worth noting that the rat TAL transcriptome analysis by Dr. Mark Knepper (National Institutes of Health) identified P2X receptor expression with the P2X 4 subunit showing highest relative expression levels (https://intramural.nhlbi.nih.gov/labs/ LKEM_G/LKEM/Pages/-TranscriptomicandProteomicDatabases. aspx). However, in P2X 4 Ϫ/Ϫ mice the ATP-triggered reduction of NaCl transport was not absent. These results imply that other remaining P2X subunits replace the function of the P2X 4 receptor component. Currently, we speculate that basolateral mTAL P2X receptors assemble as heterotrimers of P2X 4 together with the P2X 5 subunit. Further studies are required to define this. P2X 5 receptor knockout mice are currently not yet available. P2X1  5  0  5  3  1  4  P2X2  5  2  7  0  3  3  P2X3  5  2  7  0  4  4  P2X4  5  0  5  3  0  3  P2X5  5  0  5  3  0  3  P2X6  3  5  8  1  3  4  P2X7  6  0  6  1  3  4  P2Y1  5  1  6  0  3  3  P2Y2  5  0  5  3  0  3  P2Y4  5  3  8  0  3  3  P2Y6  5  0  5  3  0  3  P2Y12  5  0  5  0  3  3  P2Y13  5  0  5  0  3  3  P2Y14  5  0  5  0  3  3 ISOM, inner stripe of the outer medulla; mTAL, medullary thick ascending limb of Henle's loop; n, no. of tubules. The mechanism of how activation of a basolateral P2X receptor triggers a marked transport inhibition is not studied here. Either one or several of the molecular players of transcellular NaCl absorption (NKCC2, ROMK, ClCkb, Na-KATPase) could be affected. Also, the tight junction permeability could be regulated, leading to a reduction of the lumenpositive voltage. The unchanged R te values would argue against this. An increase in [Ca 2ϩ ] i is suggested to be not involved in this effect because stimulation of the Ca 2ϩ -sensing receptor triggers a similar increase in [Ca 2ϩ ] i as does ATP, however, leaving V te unaffected (data not shown). Similarly, basolateral UTP triggers an increase in [Ca 2ϩ ] i (5) but has no apparent effect on transport. Further studies are underway to define the cellular transduction mechanism that will explain the action of basolateral P2X receptor stimulation.
Renal tubular transport is a highly regulated process that involves classic hormones such as aldosterone, AVP, or numerous locally acting paracrine factors. The receptors for these hormonal actions are either intracellular steroid receptors or G protein-coupled membrane receptors. Our study points to a principal new mechanism involved in the regulation of renal tubular transport. As shown, activation of basolateral ligandgated P2X receptors markedly inhibits NaCl absorption in mouse mTAL. Ligand-gated ion channel receptors have so far not been established as functional plasma membrane receptors involved in the regulation of tubular transport. Thus our results open a new avenue for a comprehensive understanding of renal transport regulation.
This study adds yet another facet that describes the effect of local purinergic signaling in native renal epithelia. Extracellular ATP is a signaling molecule that inhibits tubular transport in all tubular segments studied so far. This is now also reported by direct transport measurements in mouse mTAL. We summarize that basolateral ATP triggers a marked reduction of NaCl absorption. This is mediated via a basolateral P2X receptor. One molecular element of this basolateral P2X receptor is the P2X 4 subunit.
